Akili announces public company board of director nominees

Boston--(business wire)--akili interactive (“akili”), a leading digital medicine company pioneering the development of cognitive treatments through game-changing technologies, today announced the nominees for its future board of directors, effective upon the closing of akili's business combination with social capital suvretta holdings corp. i (“scs”) (nasdaq: dnaa), subject to customary closing conditions. shares of the new public company's common stock are expected to trade on nasdaq under the
AKLI Ratings Summary
AKLI Quant Ranking